Table 1.

Patient profiles at study entry.

Number	34
Age, years	33.9±12.5 years
Male/female	22/12
Microadenoma, n (%)	4 (11,7)
Macroadenoma, n (%)	30 (88,3)
Giant tumors, n (% of Macroadenoma)	6 (20)
PRL level, μg/l	719.7±2343.61